Nonhuman primate positron emission tomography neuroimaging in drug abuse research

Journal of Pharmacology and Experimental Therapeutics

Volumn 337, Issue 2, 2011, Pages 324-334

  Howell, Leonard Lee ^a,b   Murnane, Kevin Sean ^a  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,5,6,10B HEXAHYDRO 6 (4 METHYLTHIOPHENYL)PYRROLO[2,1 A]ISOQUINOLINE; 1,2,3,5,6,10B HEXAHYDRO 6 (4 METHYLTHIOPHENYL)PYRROLO[2,1 A]ISOQUINOLINE C 11; 2 (11)METHYL O N N PROPYLNORAPOMORPHINE C 11; 2BETA CARBOXYMETHOXY3BETA [4' ( 2 IODOETHENYL)PHENYL]NORTROPANE F 18; 3 AMINO 4 (2 DIMETHYLAMINOMETHYLPHENYLSULFANYL)BENZONITRILE C 11; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; 3BETA (4 CHLOROPHENYL) 2BETA [3 (4' METHYLPHENYL)ISOXAZOL 5 YL]TROPANE; 3BETA (4 CHLOROPHENYL) 2BETA TROPANECARBOXYLIC ACID PHENYL ESTER; 3BETA (4 FLUOROPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER C 11; 3BETA (4 FLUOROPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER F 18; 5 [3 (4 CHLOROPHENYL) 8 METHYL 8 AZABICYCLO[3.2.1]OCTAN 2 YL] 3 (4 METHYLPHENYL) 1,2 OXAZOLE; 7 CHLORO 3 METHYL 1 PHENYL 1,2,4,5 TETRAHYDRO 3 BENZAPIN 8 OL C 11; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ALPHA DIHYDROTETRABENAZINE C 11; CITALOPRAM; COCAINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; FALLYPRIDE F 18; FLUOROCLEBOPRIDE F 18; FLUORODEOXYGLUCOSE F 18; FLUOXETINE; METHAMPHETAMINE; N (4 FLUOROBENZYL) 2BETA PROPANOYL 3BETA (4 CHLOROPHENYL)TROPANE F 18; PHENYL 3 (4 CHLOROPHENYL) 8 METHYL 8 AZABICYCLO[3.2.1]OCTANE 2 CARBOXYLATE; RACLOPRIDE C 11; RADIOPHARMACEUTICAL AGENT; RTI 112; RTI 177; RTI 336; SEROTONIN ANTAGONIST; SEROTONIN TRANSPORTER; UNCLASSIFIED DRUG; VANOXERINE; VESICULAR MONOAMINE TRANSPORTER; WIN 35 428;

ARTICLE; BRAIN BLOOD FLOW; BRAIN FUNCTION; BRAIN METABOLISM; BRAIN REGION; DOPAMINERGIC SYSTEM; DRUG BINDING; DRUG CLEARANCE; DRUG POTENTIATION; DRUG TARGETING; DRUG UPTAKE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; ISOTOPE LABELING; NERVE STIMULATION; NEUROTRANSMITTER RELEASE; NONHUMAN; OPTICAL RESOLUTION; POSITRON EMISSION TOMOGRAPHY; PRIMATE; PRIORITY JOURNAL; SUBSTANCE ABUSE;

ANIMALS; BIOLOGICAL MARKERS; BRAIN CHEMISTRY; CEREBROVASCULAR CIRCULATION; COCAINE; DIAGNOSTIC IMAGING; NEUROTRANSMITTER AGENTS; PHARMACEUTICAL PREPARATIONS; POSITRON-EMISSION TOMOGRAPHY; PRIMATES; RECEPTORS, DRUG; SUBSTANCE-RELATED DISORDERS; TISSUE DISTRIBUTION; TRANSLATIONAL MEDICAL RESEARCH;

EID: 79955030788     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.108.136689     Document Type: Article

References (87)

1. Andersen ML, Kessler E, Murnane KS, McClung JC, Tufik S, and Howell LL (2010) Dopamine transporter-related effects of modafinil in rhesus monkeys. Psychopharmacology (Berl) 210:439-448.
2. Anderson AL, Reid MS, Li SH, Holmes T, Shemanski L, Slee A, Smith EV, Kahn R, Chiang N, Vocci F, et al. (2009) Modafinil for the treatment of cocaine dependence. Drug Alcohol Depend 104:133-139.
3. Banks ML, Czoty PW, Gage HD, Bounds MC, Garg PK, Garg S, and Nader MA (2008) Effects of cocaine and MDMA self-administration on serotonin transporter availability in monkeys. Neuropsychopharmacology 33:219-225. (Pubitemid 350243361)
4. Banks ML, Sprague JE, Kisor DF, Czoty PW, Nichols DE, and Nader MA (2007) Ambient temperature effects on 3,4-methylenedioxymethamphetamine-induced thermodysregulation and pharmacokinetics in male monkeys. Drug Metab Dispos 35:1840-1845. (Pubitemid 47481576)
5. Breiter HC, Gollub RL, Weisskoff RM, Kennedy DN, Makris N, Berke JD, Goodman JM, Kantor HL, Gastfriend DR, Riorden JP, et al. (1997) Acute effects of cocaine on human brain activity and emotion. Neuron 19:591-611. (Pubitemid 27430747)
6. Brevard ME, Meyer JS, Harder JA, and Ferris CF (2006) Imaging brain activity in conscious monkeys following oral MDMA ("ecstasy"). Magn Reson Imaging 24: 707-714. (Pubitemid 43974892)
7. Childress AR, Mozley PD, McElgin W, Fitzgerald J, Reivich M, and O'Brien CP (1999) Limbic activation during cue-induced cocaine craving. Am J Psychiatry 156:11-18. (Pubitemid 29034874)
8. Czoty PW, Gage HD, and Nader MA (2005) PET imaging of striatal dopamine D2 receptors in nonhuman primates: Increases in availability produced by chronic raclopride treatment. Synapse 58:215-219. (Pubitemid 41690804)
9. Czoty PW, Ginsburg BC, and Howell LL (2002) Serotonergic attenuation of the reinforcing and neurochemical effects of cocaine in squirrel monkeys. J Pharmacol Exp Ther 300:831-837. (Pubitemid 34164986)
10. Czoty PW, Morgan D, Shannon EE, Gage HD, and Nader MA (2004) Characterization of dopamine D1 and D2 receptor function in socially housed cynomolgus monkeys self-administering cocaine. Psychopharmacology (Berl) 174:381-388. (Pubitemid 39044296)
11. Czoty PW, Reboussin BA, Calhoun TL, Nader SH, and Nader MA (2007) Long-term cocaine self-administration under fixed-ratio and second-order schedules in monkeys. Psychopharmacology (Berl) 191:287-295. (Pubitemid 46354623)
12. Czoty PW, Riddick NV, Gage HD, Sandridge M, Nader SH, Garg S, Bounds M, Garg PK, and Nader MA (2009) Effect of menstrual cycle phase on dopamine D2 receptor availability in female cynomolgus monkeys. Neuropsychopharmacology 34:548-554.
13. Dackis CA, Kampman KM, Lynch KG, Pettinati HM, and O'Brien CP (2005) A double-blind, placebo-controlled trial of modafinil for cocaine dependence. Neuropsychopharmacology 30:205-211. (Pubitemid 40024415)
14. Dackis CA, Lynch KG, Yu E, Samaha FF, Kampman KM, Cornish JW, Rowan A, Poole S, White L, and O'Brien CP (2003) Modafinil and cocaine: A double-blind, placebo-controlled drug interaction study. Drug Alcohol Depend 70:29-37. (Pubitemid 36385151)
15. Devinsky O, Morrell MJ, and Vogt BA (1995) Contributions of anterior cingulate cortex to behaviour. Brain 118:279-306.
16. Dewey SL, Smith GS, Logan J, Brodie JD, Yu DW, Ferrieri RA, King PT, MacGregor RR, Martin TP, and Wolf AP (1992) GABAergic inhibition of endogenous dopamine release measured in vivo with 11C-raclopride and positron emission tomography. J Neurosci 12:3773-3780.
17. Fantegrossi WE, Bauzo RM, Manvich DM, Morales JC, Votaw JR, Goodman MM, and Howell LL (2009) Role of dopamine transporters in the behavioral effects of 3,4-methylenedioxymethamphetamine (MDMA) in nonhuman primates. Psychopharmacology (Berl) 205:337-347.
18. Fantegrossi WE, Ullrich T, Rice KC, Woods JH, and Winger G (2002) 3,4- Methylenedioxymethamphetamine (MDMA, "ecstasy") and its stereoisomers as reinforcers in rhesus monkeys: Serotonergic involvement. Psychopharmacology (Berl) 161:356-364. (Pubitemid 34595786)
19. Fantegrossi WE, Woolverton WL, Kilbourn M, Sherman P, Yuan J, Hatzidimitriou G, Ricaurte GA, Woods JH, and Winger G (2004) Behavioral and neurochemical consequences of long-term intravenous self-administration of MDMA and its enantiomers by rhesus monkeys. Neuropsychopharmacology 29:1270-1281. (Pubitemid 38780650)
20. Fowler JS, Kroll C, Ferrieri R, Alexoff D, Logan J, Dewey SL, Schiffer W, Schlyer D, Carter P, King P, et al. (2007) PET studies of D-methamphetamine pharmacokinetics in primates: Comparison with L-methamphetamine and (-)-cocaine. J Nucl Med 48:1724-1732. (Pubitemid 47577345)
21. Fowler JS, Volkow ND, Wolf AP, Dewey SL, Schlyer DJ, Macgregor RR, Hitzemann R, Logan J, Bendriem B, and Gatley SJ (1989) Mapping cocaine binding sites in human and baboon brain in vivo. Synapse 4:371-377. (Pubitemid 20044793)
22. 11C]FLB 457 in the human cortex. Synapse 64:879-885.
23. Fuster JM (1997) Network memory. Trends Neurosci 20:451-459. (Pubitemid 27421707)
24. Ginsburg BC, Kimmel HL, Carroll FI, Goodman MM, and Howell LL (2005) Interaction of cocaine and dopamine transporter inhibitors on behavior and neurochemistry in monkeys. Pharmacol Biochem Behav 80:481-491. (Pubitemid 40299350)
25. Hart CL, Haney M, Vosburg SK, Rubin E, and Foltin RW (2008) Smoked cocaine self-administration is decreased by modafinil. Neuropsychopharmacology 33:761-768. (Pubitemid 351252706)
26. Hashimoto K, Tsukada H, Nishiyama S, Fukumoto D, Kakiuchi T, and Iyo M (2007) Protective effects of minocycline on the reduction of dopamine transporters in the striatum after administration of methamphetamine: A positron emission tomography study in conscious monkeys. Biol Psychiatry 61:577-581. (Pubitemid 46328849)
27. Henry PK, Murnane KS, Votaw JR, and Howell LL (2010) Acute brain metabolic effects of cocaine in rhesus monkeys with a history of cocaine use. Brain Imaging Behav 4:212-219.
28. Howell LL, Carroll FI, Votaw JR, Goodman MM, and Kimmel HL (2007) Effects of combined dopamine and serotonin transporter inhibitors on cocaine selfadministration in rhesus monkeys. J Pharmacol Exp Ther 320:757-765. (Pubitemid 46147957)
29. Howell LL, Hoffman JM, Votaw JR, Landrum AM, and Jordan JF (2001) An apparatus and behavioral training protocol to conduct positron emission tomography (PET) neuroimaging in conscious rhesus monkeys. J Neurosci Methods 106:161-169. (Pubitemid 32372527)
30. Howell LL, Hoffman JM, Votaw JR, Landrum AM, Wilcox KM, and Lindsey KP (2002) Cocaine-induced brain activation determined by positron emission tomography neuroimaging in conscious rhesus monkeys. Psychopharmacology (Berl) 159:154-160. (Pubitemid 34146558)
31. Howell LL, Votaw JR, Goodman MM, and Lindsey KP (2010) Cortical activation during cocaine use and extinction in rhesus monkeys. Psychopharmacology (Berl) 208:191-199.
32. Ito R, Dalley JW, Robbins TW, and Everitt BJ (2002) Dopamine release in the dorsal striatum during cocaine-seeking behavior under the control of a drug-associated cue. J Neurosci 22:6247-6253. (Pubitemid 35387665)
33. Jenkins BG, Sanchez-Pernaute R, Brownell AL, Chen YC, and Isacson O (2004) Mapping dopamine function in primates using pharmacologic magnetic resonance imaging. J Neurosci 24:9553-9560. (Pubitemid 39441509)
34. Johnson B, Lamki L, Fang B, Barron B, Wagner L, Wells L, Kenny P, Overton D, Dhother S, Abramson D, et al. (1998) Demonstration of dose-dependent global and regional cocaine-induced reductions in brain blood flow using a novel approach to quantitative single photon emission computerized tomography. Neuropsychopharmacology 18:377-384. (Pubitemid 28140663)
35. Kilts CD, Schweitzer JB, Quinn CK, Gross RE, Faber TL, Muhammad F, Ely TD, Hoffman JM, and Drexler KP (2001) Neural activity related to drug craving in cocaine addiction. Arch Gen Psychiatry 58:334-341. (Pubitemid 32299529)
36. Kimmel HL, Negus SS, Wilcox KM, Ewing SB, Stehouwer J, Goodman MM, Votaw JR, Mello NK, Carroll FI, and Howell LL (2008) Relationship between rate of drug uptake in brain and behavioral pharmacology of monoamine transporter inhibitors in rhesus monkeys. Pharmacol Biochem Behav 90:453-462.
37. Kimmel HL, O'Connor JA, Carroll FI, and Howell LL (2007) Faster onset and dopamine transporter selectivity predict stimulant and reinforcing effects of cocaine analogs in squirrel monkeys. Pharmacol Biochem Behav 86:45-54. (Pubitemid 46274968)
38. Kirkland Henry P, Davis M, and Howell LL (2009) Effects of cocaine selfadministration history under limited and extended access conditions on in vivo striatal dopamine neurochemistry and acoustic startle in rhesus monkeys. Psychopharmacology (Berl) 205:237-247.
39. Kufahl PR, Li Z, Risinger RC, Rainey CJ, Wu G, Bloom AS, and Li SJ (2005) Neural responses to acute cocaine administration in the human brain detected by fMRI. Neuroimage 28:904-914. (Pubitemid 41713625)
40. Laruelle M (2000) Imaging synaptic neurotransmission with in vivo binding competition techniques: A critical review. J Cereb Blood Flow Metab 20:423-451. (Pubitemid 30164887)
41. Letchworth SR, Nader MA, Smith HR, Friedman DP, and Porrino LJ (2001) Progression of changes in dopamine transporter binding site density as a result of cocaine self-administration in rhesus monkeys. J Neurosci 21:2799-2807. (Pubitemid 32298221)
42. Lindsey KP, Wilcox KM, Votaw JR, Goodman MM, Plisson C, Carroll FI, Rice KC, and Howell LL (2004) Effects of dopamine transporter inhibitors on cocaine selfadministration in rhesus monkeys: Relationship to transporter occupancy determined by positron emission tomography neuroimaging. J Pharmacol Exp Ther 309:959-969. (Pubitemid 38669681)
43. London ED, Cascella NG, Wong DF, Phillips RL, Dannals RF, Links JM, Herning R, Grayson R, Jaffe JH, and Wagner HN Jr (1990) Cocaine-induced reduction of glucose utilization in human brain. A study using positron emission tomography and [fluorine 18]-fluorodeoxyglucose. Arch Gen Psychiatry 47:567-574. (Pubitemid 20189969)
44. Maas LC, Lukas SE, Kaufman MJ, Weiss RD, Daniels SL, Rogers VW, Kukes TJ, and Renshaw PF (1998) Functional magnetic resonance imaging of human brain activation during cue-induced cocaine craving. Am J Psychiatry 155:124-126. (Pubitemid 28037560)
45. Mach RH, Nader MA, Ehrenkaufer RL, Line SW, Smith CR, Gage HD, and Morton TE (1997) Use of positron emission tomography to study the dynamics of psychostimulant-induced dopamine release. Pharmacol Biochem Behav 57: 477-486. (Pubitemid 27296759)
46. Martinez D, Narendran R, Foltin RW, Slifstein M, Hwang DR, Broft A, Huang Y, Cooper TB, Fischman MW, Kleber HD, et al. (2007) Amphetamine-induced dopamine release: Markedly blunted in cocaine dependence and predictive of the choice to self-administer cocaine. Am J Psychiatry 164:622-629. (Pubitemid 46650194)
47. Melega WP, Jorgensen MJ, Laćan G, Way BM, Pham J, Morton G, Cho AK, and Fairbanks LA (2008) Long-term methamphetamine administration in the vervet monkey models aspects of a human exposure: Brain neurotoxicity and behavioral profiles. Neuropsychopharmacology 33:1441-1452. (Pubitemid 351521710)
48. Morgan D, Grant KA, Gage HD, Mach RH, Kaplan JR, Prioleau O, Nader SH, Buchheimer N, Ehrenkaufer RL, and Nader MA (2002) Social dominance in monkeys: Dopamine D2 receptors and cocaine self-administration. Nat Neurosci 5:169-174. (Pubitemid 34121585)
49. Mukherjee J, Yang ZY, Lew R, Brown T, Kronmal S, Cooper MD, and Seiden LS (1997) Evaluation of D-amphetamine effects on the binding of dopamine D-2 receptor radioligand, 18F-fallypride in nonhuman primates using positron emission tomography. Synapse 27:1-13. (Pubitemid 27327597)
50. Murnane KS, Fantegrossi WE, Godfrey JR, Banks ML, and Howell LL (2010) Endocrine and neurochemical effects of MDMA and its stereoisomers in rhesus monkeys. J Pharmacol Exp Ther 334:642-650.
51. Murnane KS and Howell LL (2010) Development of an apparatus and methodology for conducting functional magnetic resonance imaging (fMRI) with pharmacological stimuli in conscious rhesus monkeys. J Neurosci Methods 191:11-20.
52. Murnane KS, Murai N, Howell LL, and Fantegrossi WE (2009) Discriminative stimulus effects of psychostimulants and hallucinogens in S(+)-3,4- methylenedioxymethamphetamine (MDMA) and R(-)-MDMA trained mice. J Pharmacol Exp Ther 331:717-723.
53. Nader MA and Czoty PW (2005) PET imaging of dopamine D2 receptors in monkey models of cocaine abuse: Genetic predisposition versus environmental modulation. Am J Psychiatry 162:1473-1482. (Pubitemid 41105561)
54. Nader MA, Czoty PW, Gould RW, and Riddick NV (2008) Review. Positron emission tomography imaging studies of dopamine receptors in primate models of addiction. Philos Trans R Soc London B Biol Sci 363:3223-3232.
55. Nader MA, Morgan D, Gage HD, Nader SH, Calhoun TL, Buchheimer N, Ehrenkaufer R, and Mach RH (2006) PET imaging of dopamine D2 receptors during chronic cocaine self-administration in monkeys. Nat Neurosci 9:1050-1056. (Pubitemid 44264918)
56. 11C]NPA) in an anesthetized nonhuman primate. Synapse 61: 106-109. (Pubitemid 44927734)
57. Pearlson GD, Jeffery PJ, Harris GJ, Ross CA, Fischman MW, and Camargo EE (1993) Correlation of acute cocaine-induced changes in local cerebral blood flow with subjective effects. Am J Psychiatry 150:495-497. (Pubitemid 23072480)
58. Phelps ME and Mazziotta JC (1985) Positron emission tomography: Human brain function and biochemistry. Science 228:799-809. (Pubitemid 15021439)
59. Porrino LJ, Lyons D, Miller MD, Smith HR, Friedman DP, Daunais JB, and Nader MA (2002) Metabolic mapping of the effects of cocaine during the initial phases of self-administration in the nonhuman primate. J Neurosci 22:7687-7694. (Pubitemid 35386368)
60. Saadat KS, Elliott JM, Green AR, and Moran PM (2006) High-dose MDMA does not result in long-term changes in impulsivity in the rat. Psychopharmacology (Berl) 188:75-83. (Pubitemid 44268243)
61. Scheffel U, Szabo Z, Mathews WB, Finley PA, Dannals RF, Ravert HT, Szabo K, Yuan J, and Ricaurte GA (1998) In vivo detection of short- and long-term MDMA neurotoxicity-A positron emission tomography study in the living baboon brain. Synapse 29:183-192. (Pubitemid 28221796)
62. Senda M, Kimura Y, and Herscovitch P (2002) Brain Imaging Using PET. Academic Press, New York.
63. 11C]raclopride. Synapse 59:260-269. (Pubitemid 43271734)
64. Sleight AJ, Stam NJ, Mutel V, and Vanderheyden PM (1996) Radiolabelling of the human 5-HT2A receptor with an agonist, a partial agonist and an antagonist: Effects on apparent agonist affinities. Biochem Pharmacol 51:71-76.
65. 18F]fallypride in vivo binding to D(2) receptors in striatal and extrastriatal regions of the primate brain: Single bolus and bolus plus constant infusion studies. Synapse 54:46-63. (Pubitemid 39129673)
66. Tokunaga M, Seneca N, Shin RM, Maeda J, Obayashi S, Okauchi T, Nagai Y, Zhang MR, Nakao R, Ito H, et al. (2009) Neuroimaging and physiological evidence for involvement of glutamatergic transmission in regulation of the striatal dopaminergic system. J Neurosci 29:1887-1896.
67. 18F]MPPF binding: A continuous infusion PET study in conscious monkeys. Synapse 59:18-26. (Pubitemid 41706151)
68. van Berckel BN, Kegeles LS, Waterhouse R, Guo N, Hwang DR, Huang Y, Narendran R, Van Heertum R, and Laruelle M (2006) Modulation of amphetamineinduced dopamine release by group II metabotropic glutamate receptor agonist LY354740 in non-human primates studied with positron emission tomography. Neuropsychopharmacology 31:967-977.
69. 11C]WIN-35,428 positron emission tomography studies and direct in vitro determinations. J Neurosci 18: 419-427. (Pubitemid 28046799)
70. 11C] WIN35,428 PET scans. Synapse 32:44-50. (Pubitemid 29124096)
71. Vogt BA, Finch DM, and Olson CR (1992) Functional heterogeneity in cingulate cortex: The anterior executive and posterior evaluative regions. Cereb Cortex 2:435-443.
72. Volkow ND, Ding YS, Fowler JS, Wang GJ, Logan J, Gatley JS, Dewey S, Ashby C, Liebermann J, and Hitzemann R (1995) Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in the human brain. Arch Gen Psychiatry 52:456-463.
73. Volkow ND, Fowler JS, Gatley SJ, Dewey SL, Wang GJ, Logan J, Ding YS, Franceschi D, Gifford A, Morgan A, et al. (1999) Comparable changes in synaptic dopamine induced by methylphenidate and by cocaine in the baboon brain. Synapse 31:59-66. (Pubitemid 29009280)
74. Volkow ND, Fowler JS, Logan J, Alexoff D, Zhu W, Telang F, Wang GJ, Jayne M, Hooker JM, Wong C, et al. (2009) Effects of modafinil on dopamine and dopamine transporters in the male human brain: Clinical implications. Jama 301:1148-1154.
75. Volkow ND, Wang GJ, Fischman MW, Foltin RW, Fowler JS, Abumrad NN, Vitkun S, Logan J, Gatley SJ, Pappas N, et al. (1997) Relationship between subjective effects of cocaine and dopamine transporter occupancy. Nature 386: 827-830. (Pubitemid 27181255)
76. Volkow ND, Wang GJ, Telang F, Fowler JS, Logan J, Childress AR, Jayne M, Ma Y, and Wong C (2008) Dopamine increases in striatum do not elicit craving in cocaine abusers unless they are coupled with cocaine cues. Neuroimage 39: 1266-1273.
77. Votaw JR, Howell LL, Martarello L, Hoffman JM, Kilts CD, Lindsey KP, and Goodman MM (2002) Measurement of dopamine transporter occupancy for multiple injections of cocaine using a single injection of [F-18]FECNT. Synapse 44:203-210. (Pubitemid 34496645)
78. Wallace EA, Wisniewski G, Zubal G, vanDyck CH, Pfau SE, Smith EO, Rosen MI, Sullivan MC, Woods SW, and Kosten TR (1996) Acute cocaine effects on absolute cerebral blood flow. Psychopharmacology 128:17-20. (Pubitemid 26379261)
79. Weerts EM, Fantegrossi WE, and Goodwin AK (2007) The value of nonhuman primates in drug abuse research. Exp Clin Psychopharmacol 15:309-327. (Pubitemid 47445259)
80. Wexler BE, Gottschalk CH, Fulbright RK, Prohovnik I, Lacadie CM, Rounsaville BJ, and Gore JC (2001) Functional magnetic resonance imaging of cocaine craving. Am J Psychiatry 158:86-95. (Pubitemid 32047251)
81. Wilcox KM, Kimmel HL, Lindsey KP, Votaw JR, Goodman MM, and Howell LL (2005) In vivo comparison of the reinforcing and dopamine transporter effects of local anesthetics in rhesus monkeys. Synapse 58:220-228. (Pubitemid 41690805)
82. Wilcox KM, Lindsey KP, Votaw JR, Goodman MM, Martarello L, Carroll FI, and Howell LL (2002) Self-administration of cocaine and the cocaine analog RTI-113: Relationship to dopamine transporter occupancy determined by PET neuroimaging in rhesus monkeys. Synapse 43:78-85. (Pubitemid 33115670)
83. Wilcox KM, Zhou Y, Wong DF, Alexander M, Rahmim A, Hilton J, and Weed MR (2008) Blood levels and DA transporter occupancy of orally administered methylphenidate in juvenile rhesus monkeys measured by high resolution PET. Synapse 62:950-952.
84. Winsauer PJ, McCann UD, Yuan J, Delatte MS, Stevenson MW, Ricaurte GA, and Moerschbaecher JM (2002) Effects of fenfluramine, m-CPP and triazolam on repeated-acquisition in squirrel monkeys before and after neurotoxic MDMA administration. Psychopharmacology (Berl) 159:388-396. (Pubitemid 34143363)
85. Xiao ZW, Cao CY, Wang ZX, Li JX, Liao HY, and Zhang XX (2006) Changes of dopamine transporter function in striatum during acute morphine addiction and its abstinence in rhesus monkey. Chin Med J (Engl) 119:1802-1807.
86. 11C]DASB in conscious common marmosets: Comparison with rhesus monkeys. Synapse 64:594-601.
87. Zolkowska D, Jain R, Rothman RB, Partilla JS, Roth BL, Setola V, Prisinzano TE, and Baumann MH (2009) Evidence for the involvement of dopamine transporters in behavioral stimulant effects of modafinil. J Pharmacol Exp Ther 329: 738-746.